Dentsply Sirona posted revenues of $961 million for the recent quarter, a 6.2% year-on-year increase that surpassed analyst estimates by 4.2%. However, the company is grappling with a projected 1-3% decline in operational sales for 2026 and a significant 10.6% drop in adjusted earnings per share year-over-year. To address these challenges, Dentsply is executing a restructuring plan aimed at $120 million in annual cost savings while reallocating $130 million towards debt reduction and share repurchases, focusing on growth through enhanced digital-implant workflows and R&D investment.
“Dentsply Sirona · reported revenues of · $961 million · up 6.2% year on year”
“Dentsply Sirona · exceeded analysts’ expectations by · 4.2%”
“Dentsply Sirona · is down · 7.9%”
“DENTSPLY SIRONA XRAY · is well positioned for · growth · new digital-implant workflow and continued focus on research and development”
“DENTSPLY SIRONA XRAY · has gained · 1.5% · year to date”
“DENTSPLY SIRONA XRAY · has a market capitalization of · $2.24 billion”
“DENTSPLY SIRONA XRAY · anticipates earnings to improve by · 5.9% · over the next five years”
“DENTSPLY SIRONA XRAY · is targeting · $120 million · in annual cost savings through restructuring”
“DENTSPLY SIRONA XRAY · is reallocating · ~$130 million · annually toward debt reduction and share repurchases”
“DENTSPLY SIRONA XRAY · projects · 1–3% operational sales decline · in 2026”
“DENTSPLY SIRONA XRAY · indicates a decrease of · 2.9% · in revenues from the 2025 level”
“DENTSPLY SIRONA XRAY · indicates a decline of · 10.6% · in adjusted earnings per share year-over-year”